Absolute improvements in freedom from distant recurrence with adjuvant endocrine therapies for premenopausal women with hormone receptor-positive (HR+) HER2-negative breast cancer (BC): Results from TEXT and SOFT - Regan, M M; Francis, P A; Pagani, O (J Clin Oncol, 2018)
(Suppl.)